Search images on Google Product Monograph
Active Ingredients:
- burosumab, 20 MG/ML
DIN: 02483637
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: KYOWA KIRIN, INC.
ATC:
- M05 - DRUGS FOR TREATMENT OF BONE DISEASES (ATC, WHO, Wiki)
- M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, WHO)
- M05BX - Other drugs affecting bone structure and mineralization (ATC, WHO)
- M05BX05 - BUROSUMAB (WHO)
Pharmaceutical standard: MFR